Neuroscience and inflammation biotech Contineum Therapeutics files for a $150 million IPO

Retrieved on: 2024-03-15 21:52:37

Tags for this article:

Click the tags to see associated articles and topics

Neuroscience and inflammation biotech Contineum Therapeutics files for a $150 million IPO. View article details on HISWAI: https://www.renaissancecapital.com/IPO-Center/News/103752/Neuroscience-and-inflammation-biotech-Contineum-Therapeutics-files-for-a-%241

Summary

The article discusses Contineum Therapeutics' IPO filing, highlighting their Biotech focus on developing treatments for unmet medical needs, including Idiopathic Pulmonary Fibrosis (IPF).

Article found on: www.renaissancecapital.com

View Original Article